Variant · Snv
ELAC2 NM_018127.7(ELAC2):c.2342G>A (p.Arg781His)
CI-VAR-00005452Explore in graph →p.Arg781HisNM_018127.7:c.2342G>AClinVar 5058 rs119484086
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 5058 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Prostate cancer, hereditary, 2; Combined oxidative phosphorylation defect type 17; Inborn genetic diseases; ELAC2-related disorders | germline | 14 | Sep 02, 2026 | clinvar |